Mixed effects of restriction strategies in antimicrobial stewardship programs on antimicrobial use in 121 tertiary hospitals in China, 2013–2017

References

• Holloway K, van Dijk L. The World medicines situation 2011: rational use of medicines. Geneva: WHO; 2011.
   Google Scholar
• Li Y. China’s misuse of antibiotics should be curbed. BMJ. 2014;348:g1083.
   PubMedGoogle Scholar
• World Health Organization. Using indicators to measure country pharmaceutical situations: fact book on WHO level one and level two monitoring indicators. Geneva: WHO; 2006.
   Google Scholar
• World Health Organization. Antibiotic resistance: multi-country public awareness survey. Geneva: WHO; 2015.
   Google Scholar
• World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance 2015. Geneva: WHO; 2015.
   Google Scholar
• World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2016–2017. Geneva: WHO; 2017.
   Google Scholar
• World Health Organization. The evolving threat of antimicrobial resistance: options for action: executive summary. Geneva: WHO; 2012.
   Google Scholar
• Qazi S, Weber M, Boschi-Pinto C, et al. Global action plan for the prevention and control of pneumonia (‎GAPP)‎: report of an informal consultation. Geneva: WHO; 2008.
   Google Scholar
• Zhang ZG, Chen F, Ou Y. Impact of an antimicrobial stewardship programme on antibiotic usage and resistance in a tertiary hospital in China. J Clin Pharm Ther. 2017;42(5):579–584.
   PubMed Web of Science ®Google Scholar
• Shen JL, Pan YP, Xu YH, et al. Susceptibility of escherichia coli strains in hospitals across China: results from the CHINET antimicrobial resistance surveillance program, 2005–2014. Chin J Infect Chemother. 2016;16(2):129–140. Chinese.
   Google Scholar
• Zhang RF, Eggleston K, Rotimi V, et al. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health. 2006;2(1):6.
   PubMedGoogle Scholar
• World Health Organization. WHO urges countries to take measures to combat antimicrobial resistance. 2010 Aug 20 [cited 2018 Jun 27]. Available from: http://www.who.int/mediacentre/news/releases/2010/amr_20100820/en/last
   Google Scholar
• Tangcharoensathien V, Chanvatik S, Sommanustweechai A. Complex determinants of inappropriate use of antibiotics. Bull World Health Organ. 2018;96(2):141–144.
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62(10):e51–e77.
   PubMed Web of Science ®Google Scholar
• Claeys KC, Hopkins TL, Vega AD, et al. Fluoroquinolone restriction as an effective antimicrobial stewardship intervention. Curr Infect Dis Rep. 2018;20(5):7.
   PubMed Web of Science ®Google Scholar
• Karabay O, Kaya G, Guclu E, et al. Positive effect of restrictions on antibiotic consumption. Turk J Med Sci. 2018;48(2):361–365.
   PubMed Web of Science ®Google Scholar
• Shea KM, Hobbs ALV, Jaso TC, et al. Effect of a health care system respiratory fluoroquinolone restriction program to alter utilization and impact rates of C difficile infection. Antimicrob Agents Chemother. 2017;61(6):e00125–17.
   PubMed Web of Science ®Google Scholar
• Wanla W, Katip W, Supakul S, et al. Effects of an antimicrobial restriction system on appropriate carbapenem use in a hospital without infectious diseases consultation. Int J Gen Med. 2017;10:443–449.
   PubMed Web of Science ®Google Scholar
• Reed EE, Stevenson KB, West JE, et al. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence. 2013;4(2):158–162.
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Measures for the management of the clinical application of antimicrobial drugs. 2012 May 8 [cited 2018 Oct 15]. Available from: http://www.nhfpc.gov.cn/zwgk/wlwl/201205/347e8d20a6d442ddab626312378311b4.shtml
   Google Scholar
• Park Y, Raza S, George A, et al. The effect of formulary restrictions on patient and payer outcomes: a systematic literature review. J Manag Care Spec Pharm. 2017;23(8):893–901.
   PubMed Web of Science ®Google Scholar
• Likic R, Francetic I, Bilusic M, et al. Antibiotic use optimization program in the largest Croatian University hospital – benefits of restrictions on unlimited antibiotic use. Coll Antropol. 2007;31(1):241–246.
   PubMedGoogle Scholar
• Molayi A, Kirk A, Markley J, et al. Description of a restriction program for gram-positive antimicrobial agents at an academic medical center. Am J Infect Control. 2018;46(2):232–234.
   PubMed Web of Science ®Google Scholar
• Zhejiang survey team of the National Bureau of Statistics. Zhejiang statistics yearbook (2017). Beijing: China Statistics Press; 2017. Chinese.
   Google Scholar
• MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638–656.
   PubMed Web of Science ®Google Scholar
• Akpan MR, Ahmad R, Shebl NA, et al. A review of quality measures for assessing the impact of antimicrobial stewardship programs in hospitals. Antibiotics. 2016;5(1):5.
   Google Scholar
• Dik JW, Hendrix R, Poelman R, et al. Measuring the impact of antimicrobial stewardship programs. Expert Rev Anti Infect Ther. 2016;14(6):569–575.
   PubMed Web of Science ®Google Scholar
• World Health Organization. How to investigate drug use in health facilities: selected drug use indicators. Geneva: WHO; 1993.
   Google Scholar
• Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using stata. Texas (TX): Stata press; 2008.
   Google Scholar
• Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.
   PubMed Web of Science ®Google Scholar
• Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–355.
   PubMed Web of Science ®Google Scholar
• Abdallah M, Badawi M, Amirah MF, et al. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU. J Antimicrob Chemother. 2017;72(11):3187–3190.
   PubMed Web of Science ®Google Scholar
• Mansouri MD, Cadle RM, Agbahiwe SO, et al. Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a veterans affairs medical center. Infection. 2011;39(1):53–58.
   PubMed Web of Science ®Google Scholar
• Boel J, Andreasen V, Jarlov JO, et al. Impact of antibiotic restriction on resistance levels of escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme. J Antimicrob Chemother. 2016;71(7):2047–2051.
   PubMed Web of Science ®Google Scholar
• Altunsoy A, Aypak C, Azap A, et al. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci. 2011;8(4):339–344.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Di Biagio A, Rebesco B, et al. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol. 2001;57(6–7):529–534.
   PubMed Web of Science ®Google Scholar
• Happe LE, Clark D, Holliday E, et al. A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization. J Manag Care Spec Pharm. 2014;20(7):677–684.
   PubMed Web of Science ®Google Scholar
• Gui F, Ai F. The clinical effect of moxifloxacin tablet on mild community acquired pneumonia in outpatient and emergency settings. J Community Med. 2015;13(14): 21–22. Chinese.
   Google Scholar
• Zhang HL, Feng YF. IgM antibody of children’s mycoplasma pneumoniae in a general hospital in Xuzhou city in 2015. Int J Lab Med. 2017;38(10): 1396–1398. Chinese.
   Google Scholar
• Hameed W, Ishaque M, Gul X, et al. Does courtesy bias affect how clients report on objective and subjective measures of family planning service quality? A comparison between facility-and home-based interviews. Open Access J Contracept. 2017;9:33–43.
   PubMed Web of Science ®Google Scholar
• Baldacchino F, Bussola F, Arnoldi D, et al. An integrated pest control strategy against the Asian tiger mosquito in northern Italy: a case study. Pest Manag Sci. 2017;73(1):87–93.
   PubMed Web of Science ®Google Scholar
• Booshehri LG, Dugan J, Patel F, et al. Trauma-informed temporary assistance for needy families (TANF): a randomized controlled trial with a two-generation impact. J Child Fam Stud. 2018;27(5):1594–1604.
   PubMed Web of Science ®Google Scholar
• Seah XFV, Ong YLR, Tan SW, et al. Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women’s and children’s hospital, Singapore. Pharmacotherapy. 2014;34(11):1141–1150.
   PubMed Web of Science ®Google Scholar
• Busse R, Blumel M, Knieps F, et al. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390(10097):882–897.
   PubMed Web of Science ®Google Scholar
• Nathwani D, Lawson W, Dryden M, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21:S47–S55.
   PubMed Web of Science ®Google Scholar